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Summary
Background Sunlight contains ultraviolet (UV)A and UVB radiation. UVB is essential
for vitamin D synthesis but is the main cause of sunburn and skin cancer. Sun-
screen use is advocated to reduce the sun’s adverse effects but may compromise
vitamin D status.
Objectives To assess the ability of two intervention sunscreens to inhibit vitamin D
synthesis during a week-long sun holiday.
Methods The impact of sunscreens on vitamin D status was studied during a
1-week sun holiday in Tenerife (28° N). Comparisons were made between two
formulations, each with a sun protection factor (SPF) of 15. The UVA-protection
factor (PF) was low in one case and high in the other. Healthy Polish volunteers
(n = 20 per group) were given the sunscreens and advised on the correct appli-
cation. Comparisons were also made with discretionary sunscreen use (n = 22)
and nonholiday groups (518° N, n = 17). Sunscreen use in the intervention
groups was measured. Behaviour, UV radiation exposure, clothing cover and sun-
burn were monitored. Serum 25-hydroxyvitamin D3 [25(OH)D3] was assessed
by high-performance liquid chromatography–tandem mass spectrometry.
Results Use of intervention sunscreens was the same (P = 060), and both equally
inhibited sunburn, which was present in the discretionary use group. There was
an increase (P < 0001) in mean  SD 25(OH)D3 (280  165 nmol L1) in
the discretionary use group. The high and low UVA-PF sunscreen groups showed
statistically significant increases (P < 0001) of 190  142 and 130  114
nmol L1 25(OH)D3, respectively with P = 0022 for difference between the inter-
vention sunscreens. The nonholiday group showed a fall (P = 008) of 25  56
nmol L1 25(OH)D3.
Conclusions Sunscreens may be used to prevent sunburn yet allow vitamin D syn-
thesis. A high UVA-PF sunscreen enables significantly higher vitamin D synthesis
than a low UVA-PF sunscreen because the former, by default, transmits more
UVB than the latter.
What’s already known about this topic?
• Action spectra (wavelength dependence) for erythema and the cutaneous formation
of vitamin D overlap considerably in the ultraviolet (UV)B region.
• Theoretically, sunscreens that inhibit erythema should also inhibit vitamin D syn-
thesis.
© 2019 The Authors. British Journal of Dermatology
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• To date, studies on the inhibitory effects of sunscreens on vitamin D synthesis have
given conflicting results, possibly, in part, because people typically apply sunscreen
suboptimally.
• Many studies have design flaws.
What does this study add?
• Sunscreens (sun protection factor, SPF 15) applied at sufficient thickness to inhibit
sunburn during a week-long holiday with a very high UV index still allow a highly
significant improvement of serum 25-hydroxyvitamin D3 concentration.
• An SPF 15 formulation with high UVA protection enables better vitamin D synthe-
sis than a low UVA protection product. The former allows more UVB transmission.
Terrestrial solar ultraviolet radiation (UVR ~295–400 nm)
contains UVB (280–315 nm) and UVA (315–400 nm). The
maximal UVB content is ~5% but this region is three to four
orders of magnitude more damaging than UVA per unit dose
(J m2) for sunburn,1 potentially mutagenic epidermal DNA
lesions, such as cyclobutane pyrimidine dimers (CPDs),1 and
keratinocyte cancers.2
However, UVB initiates cutaneous vitamin D3 synthesis.
Indeed, most vitamin D (about 80%) is acquired from solar
exposure,3 resulting in seasonal variations in temperate cli-
mates.3,4 Vitamin D is essential for skeletal integrity and has
been associated with many other health benefits, although
these remain controversial5 or disputed.6 It also enhances the
repair of epidermal DNA photolesions.7
Solar UVR is responsible for an increasing incidence of mel-
anoma, basal cell carcinoma and squamous cell carcinoma
(SCC), particularly in white-skinned populations,8–10 for
whom sunburn is a risk factor.11,12 Much public health effort
has been spent advising those at risk to minimize solar UVR
exposure. The use of sunscreens is one approach, and there is
evidence from randomized trials that sunscreens inhibit SCC,13
actinic keratosis (a surrogate risk marker for SCC)14 and mela-
noma.15 The role of sunscreens in melanoma prevention has
also been supported by large population-based studies.16,17
However, sunscreen use may impact vitamin D status. Reviews
report that different studies reach different conclusions.18,19
There is a consensus that typical suboptimal sunscreen use
probably has a limited effect on vitamin D production.
The sun protection factor (SPF) of a sunscreen is a quantita-
tive measure of its ability to inhibit erythema. Regulatory
authorities specify many requirements for SPF determination,
one of which is an application thickness of 2 mg cm2.20
However, people typically apply much less, for example
08 mg cm2, with a commensurate reduction in SPF.21,22
Furthermore, application is often patchy with, for example,
missing facial coverage.23 Additionally, people use sunscreens
to prolong their intentional solar exposure time.24,25
The SPF primarily quantifies protection from UVB, because
this waveband is much more erythemogenic than UVA.1
However, regulatory bodies require UVA protection, the defi-
nition of which varies with regional domain.20 This UVA
protection factor (PF) is typically a qualitative index that
describes the spectral profile of the sunscreen. One de facto
consequence of increased UVA protection is a decrease in UVB
protection for a given SPF. This would be expected to have a
beneficial effect on vitamin D synthesis.
Holidays result in a highly significant enhancement of vita-
min D3 status in adults
26 and children.27 However, this was
accompanied with a high level of sunburn in adults in Tener-
ife.28 In both adults and children there were also very high
levels of epidermal CPDs, which are a determining event for
skin cancer. Sunscreen use can inhibit CPDs,29 even with very
high UVR doses when applied at a typical user application
thickness (e.g. 075 mg cm2).30 It is therefore important to
determine conditions of sun exposure that maximize benefit
and minimize risk.
The primary aim of this investigation was to assess the abil-
ity of two sunscreens to inhibit 25-hydroxyvitamin D3 [25
(OH)D3] synthesis during a week-long sun holiday in Tener-
ife. The study was designed to compare these sunscreens (in-
tervention groups) under optimal use with typical sunscreen
use (discretionary group). The secondary aim was to deter-
mine whether the different optical properties of the interven-
tion sunscreen would affect 25(OH)D3 synthesis. This was
done by formulating two SPF 15 sunscreens with different
levels of UVA protection. The hypothesis under test was that
the sunscreen with high UVA-PF (by default more UVB trans-
mission) would enable better 25(OH)D3 synthesis than the
product with low UVA-PF. We have previously reported that
sunscreen intervention in the same participants inhibited ery-
thema. In contrast, there was marked erythema with discre-
tionary sunscreen use.31
Patients and methods
The study was approved by the Ethics Committee of the Medi-
cal University of Łodz, Poland and done according to the Dec-
laration of Helsinki. All participants (n = 79) gave written
informed consent. Most were of Fitzpatrick skin type (FST) II
and III.32 The group demographics and study locations are
summarized in Tables 1 and 2. Briefly, three groups of holi-
daymakers from Łodz, Poland, spent a week during March
© 2019 The Authors. British Journal of Dermatology
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2011 in Tenerife (28° N) with cloudless weather at a maxi-
mum UV index (UVI) of 9, which is classified as very high
by the World Health Organization.33 Sunscreen intervention
groups A and B (each n = 20) were given three ~50-g tubes
of SPF 15 sunscreens daily with high or low UVA-PF, respec-
tively.31 Participants were instructed how to apply the sun-
screens to achieve their labelled SPF, and to use one tube in
the morning, one mid-day and one in the afternoon.
Sun-exposure behaviour was monitored half-hourly in dia-
ries,34,35 which included clothing cover to estimate the percent-
age body surface area (BSA) exposed. The time of sunscreen
application was monitored, and application thickness was esti-
mated (by weighing tubes before and after use) in cases when
the first application per tube was on 85% BSA exposed (i.e.
in swimwear). Participants with discretionary use of sun-
screen, group C (n = 22), were instructed to bring their own
sunscreens to use as normal. No instructions were given, and
use was not monitored. Control group D (n = 17) remained
in Łodz (518° N). The allocation of individuals to the four
groups depended on several factors. Group C agreed to inva-
sive procedures, which have previously been reported,31 and
group D was unwilling or unable to travel. Groups A and B
were randomized as room-sharing pairs by being sequentially
allocated to sunscreen A or B as they entered the study. Pairs
were given the same sunscreen to avoid inadvertent mixing of
product.
The full details of the holiday, participants, sunscreens, per-
sonal UVR exposures and sunburn have been previously pub-
lished.31 Briefly, standard erythema doses (SEDs)35 were
measured using personal wrist-worn electronic dosimeters and
erythema was assessed at the end of each day by reflectance
spectroscopy on five exposed body sites.
Assessment of 25-hydroxyvitamin D
Serum samples from groups A, B and C were prepared from
blood taken 24 h before and 24–48 h after the holiday. The
bloods from control group D were taken at the same times.
All samples were stored at –80 °C. 25(OH)D3 was analysed
by high-performance liquid chromatography–tandem mass
spectrometry by two independent laboratories. One was the
Department of Clinical Chemistry, Birmingham City Hospital
(BCH), Sandwell and Birmingham Hospitals NHS Trust,
Birmingham, U.K. BCH is a U.K. Clinical Pathology Accredi-
tation laboratory and a member of the Vitamin D External
Quality Assessment scheme.36 The other was the Department
of Dermatology, Bispebjerg Hospital,37 Copenhagen Univer-
sity Hospital, Copenhagen, Denmark. Pre- and postsamples
(n = 158) from a given individual were analysed in the
same batch. BCH and Bispebjerg Hospital ran two and three
aliquots from each sample, respectively, and means from
each laboratory were used. In theory, the double laboratory
analysis gave data from 316 runs, but in practice this was
307 (97%) because nine aliquots could not be analysed for
technical reasons; however, all participants provided data
from at least one pre- and postsample. BCH also assessed 25
(OH)D2.
Statistics
Sample sizes were based on a previous study of 50 adults
under controlled laboratory conditions using nonsolar UVB
Table 1 Summary of study locations, sunscreen use, age and body surface area
Group A B C D All
Main conclusions from
between-group comparisons
Location Tenerife Tenerife Tenerife Łodz NA
Sunscreen use High UVA-PF
(label SPF 15)
Low UVA-PF
(label SPF 15)
Discretionary None NA
No. participants 20 20 22 17 79
Age (years), mean  SD 33  7 38  7 33  8 34  9 34  8 No age differences (P = 020),
but B older than C (P = 0047;
ANOVA and post hoc)
BSA (m2), mean  SD 181  023 190  025 1.81  0.16 1.74  0.12 182  020 No BSA differences for M, F and
M + F (P > 01, ANOVA)
Fuller details of all aspects apart from vitamin D status are described in Narbutt et al.31 As previously reported,31 all nonvitamin D parameters
were normally distributed. Values are mean  SD. BSA, body surface area; F, female; M, male; NA, not applicable; PF, protection factor;
SPF, sun protection factor.
Table 2 Summary of skin type and sex of participants
Group A B C D All
Main conclusions from
between-group comparisons
II 13 12 15 7 47 Significant skin type difference
in all groups (P = 0047) but
lost without control group D
(P = 0.16, v2-test)
III 7 8 5 10 30
IV 0 0 2 0 2
Male 8 11 8 2 29 No sex difference in all groups
(P = 0057) or holiday
groups only (P = 053,
v2-test)
Female 12 9 14 15 50
© 2019 The Authors. British Journal of Dermatology
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with changes in 25(OH)D3 as the end point.
37 Sixteen peo-
ple completing the study were deemed sufficient to detect a
mean  SD of D233  265 nmol L1 25(OH)D3 using a
paired design (i.e. preholiday vs. postholiday) with a signifi-
cance level of 5% and 90% power. This was calculated by
Power and Sample Size Calculation version 312 (http://
Table 3 Summary of actual sun protection factor (SPF), sunscreen application, ultraviolet radiation (UVR) exposure, erythema and 25-
dihydroxyvitamin D3 [25(OH)D3] and study results
Group A B C D All
Main conclusions from
between-group comparisons
Actual SPF, mean  SD 189  28 177  27 ND NA NA No difference between SPF in
A and B (P = 07, unpaired
t-test)
Sunscreen application
thickness (mg cm2),
mean  SD
243  055 244  048 ND NA NA No difference in sunscreen
application thickness in
groups A and B (P = 06,
unpaired t-test)
UVR exposure (SED),
mean  SD
410  136 386  154 494  184 19  34 432  165a No SED difference in A, B
and C (P = 008, ANOVA)
Hours outside, mean  SD 395  65 380  64 467  100 37  39 416  87a No differences in A and B
(P = 10), but group C had
more time outdoors than A
or B (P ≤ 0014; ANOVA and
post hoc)
Erythema (reflectance
spectroscopy)31
No No Yes NA NA No differences in A and B on
five exposed body sites (P ≥
036), but C had more
erythema than A and B (P <
0001; ANOVA and post hoc)
Preholiday 25(OH)D3
(nmol L1), mean  SD
670  315 590  245 599  247 479  238 589  267 No baseline 25(OH)D3
differences in A, B, C and D
(P = 019), but A > D
(P = 0031; ANOVA and post
hoc)
Postholiday 25(OH)D3
(nmol L1), mean  SD
859  253 720  215 880  204 454  209 NA With baseline adjustment, A,
B and C higher 25(OH)D3
than D (P < 0001), C
higher than B (P < 0001)
and A (P = 0037) and A
higher than B (P = 0022;
ANOVA and post hoc)
D25(OH)D3 (nmol L
1) 190  142 130  114 280  165 –25  56 NA With baseline adjustment, A,
B and C higher 25(OH)D3
than D (P < 0001), C
higher than B (P < 0001)
and A (P = 0037) and A
higher than B (P = 0022;
ANOVA and post hoc)
P-values for pre- and postholiday
changes in 25(OH)D3
< 0001 < 0001 < 0001 0087 NA NA
Preholiday % < 50 nmol L1 25
(OH)D3
30 35 32 71 41 High % with < 50 nmol L1
25(OH)D3, particularly in
group D
Postholiday % < 50 nmol L1 25
(OH)D3
0 15 5 65 NA A reduction in % with < 50
nmol L1 25(OH)D3 in
holiday groups
Fuller details of all aspects apart from vitamin D status are described in Narbutt et al.31 As previously reported,31 all nonvitamin D parameters
were normally distributed, as are pre- and postholiday 25(OH)D3 and the differences between them. The addition of the 25(OH)D2 data
(Fig. S1; see Supporting Information) increases the combined means from ~4 to 6 nmol L1. Note that the data on sunscreen application
thickness are based on the first application from each tube to 85% of body surface area and that the group D exposure data are based on 13
of 17 volunteers from whom there was a full 7-day dataset. Values are mean  SD. ND, no data; NA, not applicable; SED, standard erythema
dose; SPF, sun protection factor. aExcludes group D.
© 2019 The Authors. British Journal of Dermatology
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biostat.mc.vanderbilt.edu/wiki/Main/PowerSampleSize). The
larger sample sizes of those in Tenerife (20–22) allowed
some leeway for the less-controlled conditions of ‘real-life’
solar UVR behaviour and the possibility of dropouts. SPSS
software v22 (IBM Corp., Armonk, NY, U.S.A.) was used for
the data analysis. Normality was determined by the Kol-
mogorov–Smirnov test, and the Bland–Altman test was used
to assess the difference between the 25(OH)D3 assessment in
the two laboratories. The relationship between the two labo-
ratories was determined by linear regression. Comparisons
between the treatment groups were made by ANOVA with post
hoc tests where necessary. This adjusts for baseline 25(OH)D
because this influences UVR response.37 Pre- and postholiday
comparisons within the same individuals were made by
paired t-tests. Group differences of categorical data were
analysed by the v2-test. The significance value was set at P <
005 and all tests were two-sided. Analyses were also made
of total 25(OH)D (i.e. D2 and D3 combined).
Results
All nonvitamin D parameters have been previously reported31
and were normally distributed. There was no overall difference
in age between the groups (P = 020, ANOVA), but the sun-
screen B group was just significantly older (mean  SD,
48  24 years) than the discretionary sunscreen group C
(P = 0047, post hoc test). The BSA and mean sunscreen appli-
cation thicknesses of the intervention sunscreens are given in
Tables 1 and 3. There was no difference (P > 01) in BSA
between any of the groups (male, female and male + female
participants), although this was significantly greater in male
participants. There was no difference in the amount of sun-
screen applied in the intervention groups (P = 060), based on
the first application from each tube over 85% BSA. The partici-
pants had FST II (60%), III (38%) and IV (3%). There was a
borderline significant difference in skin type between all
groups (P = 0047), which was lost when the control group
was excluded (P = 015). Erythema, quantified by area under
the curve with time, showed virtually no change in both sun-
screen intervention groups, and no difference between these
groups (P ≥ 036), but was marked in the discretionary sun-
screen use group. The differences were highly significant (P <
0001), showing that the sunscreen interventions inhibited ery-
thema.
Ultraviolet radiation exposure
Figure 1(a) shows the mean daily ambient UVR exposure and
the exposure profiles of the holiday groups that obtained 13–
17% of ambient exposure. The mean cumulative SED expo-
sures in the three groups (Table 3) were not significantly dif-
ferent from each other (P = 008). The mean cumulative
exposure of the groups combined was 432  165 SED,
which is equivalent to ~18 and ~11 minimal erythema doses
(MEDs) in FST II and III, respectively.38 However, there was a
difference in the number of hours outside (P = 002) (Table 3).
Post hoc multiple comparisons of hours outside showed no dif-
ferences between the two sunscreen intervention groups (~5 h
30 min daily, P = 10), each of which had significantly fewer
hours of exposure than the discretionary use group (~6 h
40 min daily, P ≤ 0014). The mean cumulative exposure in the
control group was 19  34 SED, which is < 1 MED, irrespec-
tively of FST.
Body surface area exposed, sunscreen transmittance
properties and application, and erythema assessments
We have previously shown a relationship between holiday
UVB dose and production of 25(OH)D3 after adjustment for
amount of BSA exposed.26 In effect, this is a product of
exposed BSA and SED. Thus, Figure 1(b) shows the half-
hourly product of BSA exposed (m2) 9 SED (100 J m2) to
give the total energy received (J) at the skin surface. There
was no significant difference between the three holiday groups
(P = 075, ANOVA) using individual area under the curve as the
outcome. The individual data (Fig. S2; see Supporting Infor-
mation) show a very wide range of individual behavioural
patterns.
The UVR transmittance spectra of the sunscreens are shown
in Figure 2; the inset shows that high UVA-PF sunscreen
(group A) transmitted ~20% more UVB than the low UVA-PF
sunscreen (group B).
25-Hydroxyvitamin D2 and D3, and total 25-
hydroxyvitamin D
The values of 25(OH)D2 were low with the means ranging
from 35 to 56 nmol L1. All 25(OH)D2 data were normally
distributed (P > 015) apart from preholiday sunscreen A
(P = 0022). In 26 of the 158 pre- and postsamples (165%),
both aliquot runs were at the limit of detection (28
nmol L1). The pre- and postholiday 25(OH)D2 results are
given in Figure S1 (see Supporting Information), with addi-
tional statistical information in the figure legend. There was
no significant difference between pre- and postholiday sam-
ples for the control and sunscreen A and B groups (P > 009).
However, the postholiday value was lower in the discretionary
sunscreen group C (P = 0003).
The Bland–Altman test (Fig. S3; see Supporting Informa-
tion) showed a significant (P < 0001) systematic mean differ-
ence of 73 nmol L1 25(OH)D3 (95% confidence interval
59–88) between the two laboratories. The interlaboratory
results were compared by linear regression (Fig. 3) to give an
equation of y = 101x + 673 (95% confidence interval of
slope 096–106 and intercept 306–1040) with r2 = 091
and slope P < 0001. A slope of 101 means there is no labo-
ratory bias for the D values (i.e. postholiday – preholiday).
Thus, given the excellent correlation, the mean values from
the two laboratories were used in the statistical analyses. Data
from a single laboratory were used in the nine missing cases.
Analyses were done for 25(OH)D3 and total 25(OH)D. Pre-,
postholiday and D25(OH)D3 were normally distributed (P >
© 2019 The Authors. British Journal of Dermatology
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031 with the exception of the preholiday sunscreen A group
with P = 0054). All total 25(OH)D data (preholiday, posthol-
iday and D) were also normally distributed (P > 027) except
for sunscreen A preholiday (P = 0054).
The 25(OH)D3 results are shown in Table 3. The overall
mean baseline (preholiday) 25(OH)D3 value was 589  267
nmol L1. There was no significant difference (P = 019,
ANOVA) between the baseline 25(OH)D3 values of any group, or
for total 25(OH)D (P = 022, ANOVA). However, post hoc analy-
sis showed there was a significant difference between the base-
line 25(OH)D3 of groups D and A of P = 0031 [P = 0041 for
total 25(OH)D]; importantly, such analyses showed no differ-
ences between the three holiday groups (P ≥ 034).
Table 3 also shows a nonsignificant decline of 25(OH)D3 for
the Łodz control group during the study, but highly significant
postholiday increases in all Tenerife groups. The ranking of this
increase is discretionary (group C) > high UVA-PF sunscreen
(group A) > low UVA-PF sunscreen (group B).
ANOVA showed a highly significant (P < 0001) difference
between the poststudy 25(OH)D3 values for the four groups
[P < 0001 for total 25(OH)D], after adjustment for prelevel
(baseline), and differences between the groups were tested by
post hoc analyses. The greatest differences [for 25(OH)D3 and
total 25(OH)D] were between the Łodz control and the three
Tenerife groups with P < 0001. The poststudy value in the
discretionary sunscreen group was greater than the low UVA-
PF [P < 0001 for both 25(OH)D3 and total 25(OH)D] and
high UVA-PF [P = 0037 for 25(OH)D3 and P = 0068 for
total 25(OH)D] sunscreen groups, and the increase in the lat-
ter was significantly greater [P = 0022 for 25(OH)D3 and
P = 0025 for total 25(OH)D] than the former. The baseline
adjusted postholiday group differences for 25(OH)D3 are C >
A by 72  34 nmol L1 (mean  SEM), C > B by
153  34 nmol L1 and A > B by 81  35 nmol L1
(note same P-values as above). The latter comparison supports
the hypothesis of the secondary aim, which is that better
(a)
(b)
Fig 1. Solar ultraviolet radiation exposure during the 7-day holiday in Tenerife. (a) Mean half-hourly ambient and study group exposure
[standard erythema doses (SEDs) per 05 h]. Groups A, B (sunscreen intervention) and C (discretionary sunscreen use) received 14% [95%
confidence interval (CI) 11–17], 13% (95% CI 10–16) and 17% (95% CI 14–20) of ambient, respectively (based on area under the curve). (b)
Erythemally effective energy (J) received at the skin surface. This is the product of SED (expressed as 100 J m2) and body surface area (m2)
exposed each 30 min in groups A, B and C. The individual data are shown in Figure S2 (see Supporting Information).
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vitamin D synthesis would occur with the sunscreen that
transmitted more UVB.
Table 3 shows the percentage with 25(OH)D3 > 50
nmol L1 (D3 sufficiency) in each study group before and
after the holiday. In all holiday groups, this percentage was
reduced and the 25(OH)D3 level increased in all individuals.
The sunscreen B group had three volunteers with a postholi-
day 25(OH)D3 level < 50 nmol L
1, two of whom had 25
(OH)D < 25 nmol L1 preholiday. Only one person remained
insufficient in the discretionary sunscreen group but increased
from 397 to 48 nmol L1. The Łodz control group D had a
much higher preholiday percentage of insufficiency.
There was no relationship seen between age and postholi-
day 25(OH)D3 (with correction for baseline) for all groups
combined (P = 053) and for the individual groups
(P = 053–096). There was also no significant correlation
between age and preholiday, postholiday or D25(OH)D3
values and total 25(OH)D (P > 023 all four groups, P > 019
holiday groups, P > 040 individual groups), or any significant
effect of sex on vitamin D markers in holiday groups
[P = 073 for 25(OH)D3 values and 079 for total 25(OH)D].
There was also no relationship between duration of solar
exposure and postholiday vitamin D markers (with correction
for baseline) for all holiday groups combined [P = 023 for
25(OH)D3 and P = 030 for total 25(OH)D] or for the indi-
vidual holiday groups [P = 053–068 for 25(OH)D3 and
P = 052–067 for total 25(OH)D].
Discussion
Holidays contribute substantially to UVR burden.39,40 Over 55
million northern Europeans visited the Canary Islands in
2017,41 the latitude of which is comparable with the U.S. holi-
day destination of Florida. Sunscreens are important for photo-
protection, but concerns about their possible inhibitory effects
on vitamin D3 production have been largely based on labora-
tory studies with inappropriate UVB phototherapy sources that
contain short-wave nonsolar UVB, which is very effective at
forming previtamin D3,
42 or theoretical calculations.43 In con-
trast, we studied sunscreen use under holiday conditions with
excellent weather. Furthermore, the study was designed to test
the possible inhibitory effect of sunscreens on vitamin D3 syn-
thesis under optimal conditions of use.
The study participants received an overall mean  SD of
432  165 SED (range 12–93) that was 13–17% ambient
erythemal UVR. It has been estimated that an indoor worker
in northern Europe receives ~150 SED annually on the face.40
The SED measurements were made on the wrist, but studies
have shown that this is ~50% of the facial dose,44 although
this depends on behaviour. Without any body site adjustment,
the wrist data confirm that a very high fraction of annual UVR
exposure (~30%) can be obtained in a 1-week sun holiday in
spring. Many northern Europeans take summer holidays, in
which case the doses are probably considerably higher.
In a previous Tenerife study, in March 2010, we reported
that Danes (n = 25) obtained a total of 570  247 SED
(range 21–115) over 6 days, which represented ~43% of their
annual solar UVR burden.34 This is a higher value than in the
current study and may be because sun seekers were specifically
targeted during the recruitment of the Danes. Overall, these
Fig 2. Ultraviolet radiation (UVR) transmittance of the two
intervention sunscreens. For full details of sunscreen properties,
including UVR absorption properties (as monochromatic protection
factors) see Narbutt et al.31 The inset shows the transmittance in the
UVB region. Based on area under the curve, sunscreen A (with high
UVA-protection factor) transmits ~20% more UVB than sunscreen B
(with low UVA-protection factor).
Fig 3. Linear relationship between 25(OH)D3 measurements from
two independent laboratories. The linear regression (n = 149)
equation is y = 101( 003)x + 673( 186) and the slope is
highly significant (P < 0001) with r2 = 091. Errors are SE. The
intercept is consistent with the Bland–Altman test (Fig. S3; see
Supporting Information). Colour squares refer to study group and the
shapes (Ο and D) refer to pre- and postholiday, respectively; dotted
lines represent the 50 nmol L1 boundary between vitamin D3
insufficiency and sufficiency. 25(OH)D3, 25-hydroxyvitamin D3; BBH,
Bispebjerg Hospital; BCH, Birmingham City Hospital.
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data from Tenerife support studies that estimate that a high
fraction of annual UVR burden is received during sunny holi-
days.40 Such exposure, particularly if associated with sunburn,
is probably an important risk factor for skin cancer.11,12
There was no difference in cumulative SED between the
three holiday groups, although the discretionary sunscreen use
group spent significantly more time outdoors (~1 h per day)
than the intervention groups. However, this additional time
had no effect on any of the vitamin D outcomes. This is not
surprising because photochemical reactions limit the produc-
tion of previtamin D3 after ~3 h, which in turn limits the pro-
duction of 25(OH)D3.
45 Measurements on the same
participants31 showed that sunscreens A and B equally and sig-
nificantly inhibited erythema, on five exposed body sites, in
comparison with the discretionary sunscreen group C, which
had marked erythema. Importantly, because the amount of
BSA exposed affects serum 25(OH)D3,
46 there was no signifi-
cant difference between the product of BSA exposed and SED.
Thus, we may conclude that the overall patterns of UVR expo-
sure of the three holiday groups were the same. The contem-
poraneous control group had very low UVR exposures in
Poland, where the mean  SD temperature was 58  41 °C
with a maximum UVI of 2–3.
There was no significant difference between the baseline
25(OH)D3 in any of the groups, with an overall mean  SD
(n = 79) of 589  267 nmol L1, even though the sun-
screen A group had a 191  87 nmol L1 higher 25(OH)D3
than the Łodz control group D. At least 50 nmol L1 total
25(OH)D is regarded as sufficient by the Institute of
Medicine, though different organizations use different levels
for sufficiency.47 The negative control group declined insignif-
icantly by 25  56 nmol L1 25(OH)D3, which is indicative
of the gradual loss of UVB-induced vitamin D3 reserves
acquired in summer. It should be noted that food is not
vitamin D fortified in Poland.
There was a highly significant increase of 25(OH)D3 in all
three holiday groups, which was greatest in the discretionary
sunscreen use group (280  165 nmol L1), which showed
sunburn.31 We have previously reported a mean increase of
215 nmol L1 25(OH)D3 after a mean cumulative exposure
of 570 SED over 50% BSA48 in a 6-day study of sun-worship-
ping Danes in Tenerife during March 2010.26 All participants
had sunburn28 despite discretionary sunscreen use.34
The increase in 25(OH)D3 was significantly greater with
high compared with low UVA-PF (190  142 vs.
130  114 nmol L1), which is a consequence of greater
UVB transmittance through the high UVA-PF sunscreen (see
Fig. 2). The percentage with > 50 nmol L1 (vitamin D3
sufficiency) was reduced in all groups postholiday
(Table 3). There was increased 25(OH)D3 in all individuals,
although three in the sunscreen group B and one in the
discretionary sunscreen use group C did not reach suffi-
ciency postholiday [i.e. 25(OH)D3 < 50 nmol L
1]. The
higher preholiday percentage of insufficiency in the Łodz
control group D may reflect its sun-behaviour habits as
members chose not to travel.
Based on measurements from 21 tubes per person,31 the
intervention sunscreens were applied at a mean thickness of
24 mg cm2, resulting in SPFs of at least 15. Thus, assuming
a constant level of protection, the average cumulative UVR
dose received through the sunscreen was ~40/15 (SPF) = 27
SED (or ~04 SED per day). This results in an increase of 70
and 48 nmol L1 25(OH)D3 per SED through the high and
low UVA-PF sunscreens, respectively. A recent study, with an
acute exposure of fluorescent solar-simulated radiation over
35% BSA, showed an estimated increase of ~3 and ~25
nmol L1 per SED in people of FST II and III, respectively
(L. Rhodes, personal communication).49 These results are
compatible with ours given that the relationships between 25
(OH)D3 synthesis and UVR dose and the BSA exposed are
complex.46 It was not possible to estimate the doses received
by the discretionary sunscreen use group C.
Overall, the conclusions from the group comparisons of
25(OH)D3 and total 25(OH)D were the same with one excep-
tion: the significance of the greater increase in the discre-
tionary use (group C) over high UVA-PF sunscreen (group A)
was lost when the total 25(OH)D was used. As previously
reported by others in adults50 the levels of 25(OH)D2 were
very low. Pre- vs. postholiday 25(OH)D2 did not change apart
from a fall in group C, which had the greatest increase in 25
(OH)D3. It is possible that 25(OH)D2 and 25(OH)D3 interact
with each other, but this would require additional study.
Several laboratory studies have compared the protection
from UVR-induced epidermal and dermal damage after the
application of high vs. low UVA protection, for a given
SPF.51–53 These investigations demonstrate the benefits from
better UVA protection. To the best of our knowledge, this is
the first time that higher UVA protection, for a given SPF, has
been shown to be beneficial for vitamin D synthesis. Apart
from biological benefits from increased UVA protection, the
labelled SPF is a much more robust indicator of protection
with a broad-spectrum product.54 This is because solar UVB
content, which varies considerably with the height of the sun,
is a major determinant of SPF with low UVA-PF. Furthermore,
high UVA protection is probably advantageous because there
is increasing evidence that UVA, particularly UVA1 (340–400
nm), may be more harmful than previously thought.55 For
example, the basal layer of the epidermis, which contains mel-
anocytes and proliferating keratinocytes, is particularly suscep-
tible to UVA1-induced DNA damage.56 UVA may cause
oxidative damage to DNA repair proteins.57 There are also epi-
demiological data to suggest that solar UVA may be more
important for melanoma in comparison with keratinocyte can-
cers.58,59 However, we lack definitive data for the action spec-
trum of melanoma in mammalian skin.
One strength of this investigation is that it was done
under ‘real-life’ holiday conditions during a week of cloud-
less weather with very high UVI. Furthermore, there was no
difference in cumulative SED exposure between the groups,
including after adjustment for the exposed BSA. Another
strength is that the measurements for the high-performance
liquid chromatography–tandem mass spectrometry study of
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25(OH)D3 were independently assessed in two laboratories,
including a Vitamin D External Quality Assessment
Scheme laboratory, with excellent interlaboratory agreement.
A major concern of many vitamin D studies is lack of stan-
dardization of measurements.36,60 One weakness of the study
was that the participants were not fully randomized, which
was not possible for practical and logistical reasons. How-
ever, the baseline and demographic characteristics of the
study groups were not significantly different from each other
except that sunscreen group B, which has the smallest
increase in 25(OHD)3, was older than the other groups. This
difference was of borderline significance and had no effect
on any of the vitamin D outcomes. However, it should be
noted that vitamin D synthesis decreases with age.61 Another
weakness is the lack of data on sunscreen use in the discre-
tionary group C, but collecting such data might have altered
sunscreen application behaviour, the so-called Hawthorn
effect.62 Our goal was to compare optimal with typical holi-
day sunscreen use (e.g. 079 mg cm2).22 This is important
because laboratory studies, with a UVB phototherapy source,
have shown that sunscreen application thickness has an
impact of serum 25(OH)D3.
63
In conclusion, there was an increase of 25(OH)D3 during a
week of cloudless weather with very high UVI, even when
sunscreens were used to achieve their labelled SPFs and inhibit
sunburn. We estimate that the measured increases of 25(OH)D3
occur with ~04 SED per day through the sunscreens, which is
equivalent to ~01 MED per day in fair-skinned people. Although
labelled as SPF 15, the products used in the current study were
in the region of SPF 18–19. A sunscreen with SPF 50+
(mean  SD 64  158) used at 075 mg cm2 has an SPF of
209  33.30 This means that typical use of high SPF sun-
screens probably has a limited impact on vitamin D synthesis.
However, the use of high SPF sunscreens in a way that achieves
their labelled SPF may have an impact on vitamin D synthesis,
but this needs to be tested under field conditions. There is inter-
action between the BSA exposed and UVR dose46 and this is
probably complicated by the addition of sunscreens.
Significantly more 25(OH)D3 synthesis occurred with a
high UVA-PF (broad-spectrum) sunscreen when compared
with a low UVA-PF sunscreen for a given SPF. This is what
would be expected based on the action spectrum for previta-
min D3 and the optical properties of the sunscreens. Thus,
sunscreens can be designed to optimize the balance between
the adverse and beneficial effects of solar UVR exposure as
suggested by theoretical calculations.64 Our data support the
use of sunscreens to prevent adverse effects of UVR, without
compromising vitamin D synthesis. This is in agreement with
the conclusions of two recent reviews of a wide range of dif-
ferent types of studies on the effect of sunscreen use on vita-
min D synthesis.65,66
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